Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61 (HNRNPA1P61) is classified as a *processed pseudogene* related to the HNRNPA1 gene, which encodes an RNA-binding protein involved in various aspects of mRNA processing, including splicing and regulation of mRNA transport[1][7]. Pseudogenes like HNRNPA1P61 do not produce functional proteins due to mutations such as early stop codons or frameshifts. Some pseudogenes may have regulatory roles, such as acting as decoys for regulatory RNAs or influencing gene expression by other noncoding mechanisms, but there is no published evidence that HNRNPA1P61 is transcribed or has such a role[7]. Therefore, HNRNPA1P61 is not a canonical drug target, nor is there evidence for involvement in human disease. If you require information on the functional gene *HNRNPA1* (not the pseudogene), which is a member of the heterogeneous nuclear ribonucleoproteins involved in RNA processing and associated with diverse biological processes and disease, please specify.
None (no demonstrated mechanism—pseudogenes are non-coding)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 61 (HNRNPA1P61).